Do Not Use Nitrogen or Argon Plasma Treatments for Wound Healing
Based on the most recent and highest-quality evidence, you should not use nitrogen plasma, argon plasma, or any other gas-based treatments (including cold atmospheric plasma, ozone, or nitric oxide) for wound healing in preference to standard wound care. 1
Guideline-Based Recommendation
The 2024 IWGDF (International Working Group on the Diabetic Foot) guidelines provide the strongest and most recent evidence on this topic, issuing a strong recommendation with low-quality evidence against using other gases (including cold atmospheric plasma) compared to standard care for wound healing in diabetic foot ulcers 1. This represents the current consensus position from the leading international authority on wound management.
Why This Recommendation Exists
The guideline authors reviewed available evidence and determined that:
- Insufficient clinical evidence: Despite some promising laboratory and animal studies, there is inadequate high-quality human clinical trial data to support routine use 1
- Standard care remains superior: Sharp debridement, appropriate dressings, off-loading, and infection control remain the evidence-based foundation of wound management 2, 1
- Resource allocation concerns: These technologies are expensive and not widely available, while proven standard therapies are more accessible 1
What the Research Shows (But Why It's Not Enough)
While several animal studies demonstrate potential benefits of argon and nitrogen plasma:
- Argon plasma showed accelerated healing in diabetic mice 3 and rats 4, 5
- Nitrogen/argon micro-plasma enhanced healing in laser-induced mouse wounds 6
- One small human pilot study (n=40) on skin graft donor sites showed improved healing with argon plasma 7
However, these studies have critical limitations:
- Predominantly animal models that don't translate reliably to human chronic wounds
- The single human study was small, involved acute surgical wounds (not chronic ulcers), and lacked long-term follow-up
- No large-scale randomized controlled trials in the populations that need wound healing most (diabetic ulcers, pressure ulcers, chronic wounds)
What You Should Do Instead
Follow evidence-based standard wound care 1:
- Sharp debridement as the primary method for removing necrotic tissue and debris (strong recommendation)
- Appropriate dressings selected based on exudate control, comfort, and cost
- Off-loading for foot wounds (crucial for healing)
- Infection control when indicated
- Vascular assessment and revascularization if ischemia is present
When Standard Care Fails
If wounds fail to show 50% reduction after 4 weeks of appropriate standard care 8, consider these evidence-supported adjunctive therapies before plasma treatments:
- Hyperbaric oxygen therapy for neuro-ischemic or ischemic diabetic foot ulcers (conditional recommendation, low evidence) 1
- Topical oxygen therapy where resources exist (conditional recommendation, low evidence) 1
- Negative pressure wound therapy for post-operative wounds (may reduce healing time) 1
- Sucrose-octasulfate dressings for non-infected neuro-ischemic ulcers unresponsive to 2 weeks of standard care (conditional recommendation, moderate evidence) 1
Common Pitfalls to Avoid
- Don't be swayed by promising animal data: The leap from rodent models to human chronic wounds is substantial, and plasma therapy hasn't made that leap successfully
- Don't use plasma as a substitute for proper debridement: No adjunctive therapy replaces the fundamentals of wound care 2, 9
- Don't delay proven interventions: If vascular insufficiency exists, early revascularization (within 1-2 days) is more important than any topical therapy 9
The Bottom Line
While plasma technologies may hold future promise and the basic science is intriguing, current clinical evidence does not support their use over standard wound care practices. The 2024 IWGDF guidelines represent the most authoritative, recent position on this question, and they explicitly recommend against using gas-based therapies including plasma treatments 1. Stick with proven standard care and reserve adjunctive therapies for those with established clinical evidence in human trials.